Angiotensin-converting enzyme gene insertion/deletion polymorphism in Egyptian patients with myocardial infarction

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 10, Issue 2, 2009, Pages 96-100

  Settin, Ahmad ^a,c   ElBaz, Rizk ^a   Abbas, Amr ^a   Abd Al Samad, Ayman ^a   Noaman, Ahmed ^b  

^a MANSOURA UNIVERSITY   (Egypt)

^b Mansoura University   (Egypt)

^c QASSIM UNIVERSITY   (Saudi Arabia)

Author keywords

Angiotensin converting enzyme; Egypt; Gene polymorphism; Ischaemic heart disease; Myocardial infarction

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; DNA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; EGYPT; FEMALE; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; HEART INFARCTION; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; POLYMERASE CHAIN REACTION;

ADULT; EGYPT; FEMALE; GENE DELETION; HUMANS; MALE; MIDDLE AGED; MUTAGENESIS, INSERTIONAL; MYOCARDIAL INFARCTION; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC;

EID: 67650468702     PISSN: 14703203     EISSN: None     Source Type: Journal    
DOI: 10.1177/1470320309105198     Document Type: Article

References (31)

1. Egred M., Viswanathan G., Davis GK Myocardial infarction in young adults. Postgrad Med J 2005;81:741-5.
2. Franco E., Palumbo L., Crobu F. et al. Renin-angiotensin-aldosterone system polymorphisms: A role or a hole in occurrence and long-term prognosis of acute myocardial infarction at young age. BMC Med Genet 2007;8:27.
3. Petrovic D., Zorc M., Kanic V., Peterlin B. Interaction between gene polymorphisms of renin-angiotensin system and metabolic risk factors in premature myocardial infarction. Angiology 2001;52:247-52.
4. Ranjith N., Pegoraro RJ, Rom L., Lanning PA, Naidoo DP Renin-angiotensin system and associated gene polymorphisms in myocardial infarction in young South African Indians. Cardiovasc J S Afr 2004;15:22-6.
5. Danser AH, Schalekamp MA, Bax WA et al. Angiotensin converting enzyme in the human heart: Effect of the deletion/insertion polymorphism Circulation 1995;92:1387-8.
6. Cambien F., Poirier O., Lecerf L. et al. Deletion polymorphism in the gene for angiotensin converting enzyme is a potent risk factor for myocardial infarction. Nature 1992;359:641-4.
7. Steeds RP, Wardle A., Smith PD, Martin D., Channer KS, Samani NJ Analysis of the postulated interaction between the angiotensin II sub-type receptor gene A1166C polymorphism and the insertion/deletion polymorphism of the angiotensin converting enzyme gene on risk of myocardial infarction. Atherosclerosis 2001;154:123-8.
8. Ohira N., Matsumoto T., Tamaki S. et al. Angiotensin-converting enzyme insertion/deletion polymorphism modulates coronary release of tissue plasminogen activator in response to bradykinin. Hypertens Res 2004;27:39-45.
9. Oztürk O., Oztürk U. Relation between angiotensin-converting enzyme I/D gene polymorphism and pulse pressure in patients with a first anterior acute myocardial infarction. Anadolu Kardiyol Derg 2009;9(1):9-14.
10. Ulgen MS, Ozturk O., Alan S. et al. The relationship between angiotensin-converting enzyme (insertion/deletion) gene polymorphism and left ventricular remodeling in acute myocardial infarction. Coron Artery Dis 2007;18:153-7.
11. Lindpaintner K., Pfeffer MA, Kreutz R. et al. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med 1995;332:706-11.
12. Chambless L., Keil U., Dobson A. et al. Population versus clinical view of case fatality from acute coronary heart disease: Results from the WHO MONICA Project 1985-1990. Multinational MONItoring of Trends and Determinants in CArdiovascular Disease. Circulation 1997;96:3849-59.
13. Igic R., Behnia R. Properties and distribution of angiotensin I converting enzyme. Curr Pharm Des 2003;9:697-706.
14. Dzimiri N., Basco C., Moorji A., Meyer BF Angiotensin-converting enzyme polymorphism and the risk of coronary heart disease in the Saudi male population. Arch Pathol Lab Med 2000;124:531-4.
15. Aucella F., Vigilante M., Margaglione M. et al. Polymorphism of the angiotensin-converting enzyme gene in end-stage renal failure patients. Nephron 2000;85(1):54-9.
16. Mizuiri S., Hemmi H., Inoue A. et al. Angiotensin converting enzyme polymorphism and development of diabetic nephropathy in non insulin dependent diabetes mellitus. Nephron 1995;70:455-9.
17. Sagnella GA, Rothwell MJ, Onipinla AK, Wicks PD, Cook DG, Capuccio FP A population study of ethnic variations in the angiotensin converting enzyme I/D polymorphism: Relationships with gender, hypertension and impaire glucose metabolism. J Hypertens 1999;17:657-64.
18. Jalil JE, Piddo AM, Cordova S. et al. Prevalence of the angiotensin I converting enzyme insertion/deletion polymorphism. Plasma angiotensin converting enzyme activity and left ventricular mass in a normotensive Chilean population. Am J Hypertens 1999;12:697-704.
19. Huang XH, Rantalaiho V., Wirta O. et al. Angiotensin-converting enzyme insertion/deletion polymorphism and diabetic albuminuria in patients with NIDDM followed up for 9 years. Nephron 1998;80(1):17-24.
20. Marre M., Jeunemaitre X., Gallois Y. et al. Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group. J Clin Invest 1997;99:1585-95.
21. Schmidt S., Stier E., Hartung R. et al. No association of converting enzyme insertion/deletion polymorphism with immunoglobulin A glomerulonephritis. Am J Kidney Dis 1995;26:727-31.
22. Bautista LE, Ardila ME, Gamarra G., Vargas CI, Arenas IA Angiotensin-converting enzyme gene polymorphism and risk of myocardial infarction in Colombia. Med Sci Monit 2004;10:CR473-9.
23. Agrawal S., Singh VP, Tewari S. et al. Angiotensin-converting enzyme gene polymorphism in coronary artery disease in north India. Indian Heart J 2004;56(1):44-6.
24. Hamon M., Fradin S., Denizet A., Filippi-Codaccioni E., Grollier G., Morello R. Prospective evaluation of the effect of an angiotensin I converting enzyme gene polymorphism on the long term risk of major adverse cardiac events after percutaneous coronary intervention. Heart 2003;89:321-5.
25. Zak I., Niemiec P., Sarecka B. et al. Carrier-state of D allele in ACE gene insertion/deletion polymorphism is associated with coronary artery disease, in contrast to the C677 - T transition in the MTHFR gene. Acta Biochim Pol 2003;50:527-34.
26. Acarturk E., Attila G., Bozkurt A., Akpinar O., Matyar S., Seydaoglu G. Insertion/deletion polymorphism of the angiotensin converting enzyme gene in coronary artery disease in southern Turkey. J Biochem Mol Biol 2005;38:486-90.
27. Palmer BR, Pilbrow AP, Yandle TG et al. Angiotensin-converting enzyme gene polymorphism interacts with left ventricular ejection fraction and brain natriuretic peptide levels to predict mortality after myocardial infarction. J Am Coll Cardiol 2003;41:729-36.
28. Keavney B., McKenzie C., Parish S. et al. Large-scale test of hypothesised associations between the angiotensin-converting-enzyme insertion/deletion polymorphism and myocardial infarction in about 5000 cases and 6000 controls. International Studies of Infarct Survival (ISIS) Collaborators. Lancet 2000;355:434-42.
29. Alvarez R., González P., Batalla A. et al. Association between the NOS3 (-786 T/C) and the ACE (I/D) DNA genotypes and early coronary artery disease. Nitric Oxide 2001;5:343-8.
30. Mata-Balaguer T., de la Herran R., Ruiz-Rejon C., Ruiz-Rejon M., Garrido-Ramos MA, Ruiz-Rejon F. Angiotensin converting enzyme gene and risk of coronary heart disease in a low risk Spanish population. Int J Cardiol 2004;95:145-51.
31. Sayed-Tabatabaei FA, Schut AFC, Arias Va'squez A. et al. Angiotensin converting enzyme gene polymorphism and cardiovascular morbidity and mortality: The Rotterdam Study. J Med Genet 2005;42(1):26-30.